يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Greg Deye"', وقت الاستعلام: 1.50s تنقيح النتائج
  1. 1

    مصطلحات موضوعية: Male, double blind procedure, ultra performance liquid chromatography, limit of quantitation, Clinical pharmacokinetics, diarrhea, volume of distribution, Pharmacology, 0302 clinical medicine, Elimination rate constant, aspartate aminotransferase, Pharmacology (medical), Volume of distribution, 0303 health sciences, drug dose regimen, adult, Healthy Volunteers, medicine.drug_formulation_ingredient, priority journal, oxfendazole glucuronide, First-in-human study, drug exposure, Biological Availability, bicarbonate, urinary excretion, Clinical Therapeutics, purl.org/pe-repo/ocde/ford#3.03.08 [https], Article, 03 medical and health sciences, Pharmacokinetics, Taenia solium, activated partial thromboplastin time, Humans, neutropenia, no-observed-adverse-effect level, purl.org/pe-repo/ocde/ford#3.01.05 [https], human, normal human, arthralgia, liquid chromatography-mass spectrometry, elimination half-life, Dose-Response Relationship, Drug, 030306 microbiology, maximum plasma concentration, leukopenia, drug bioavailability, major clinical study, drug metabolism, flatulence, plasma half life, time to maximum plasma concentration, randomized controlled trial, drug solubility, Benzimidazoles, drug metabolite, drug tolerability, drug safety, phase 1 clinical trial, Administration, Oral, Anthelmintic agent, Area under the curve, single drug dose, Middle Aged, sore throat, unclassified drug, Infectious Diseases, female, Tolerability, leukocytosis, Female, eosinophilia, medicine.drug, Half-Life, bicarbonate blood level, Adult, oxfendazole, Oxfendazole, pharmacokinetic parameters, Adolescent, side effect, area under the curve, 030231 tropical medicine, oxfendazole sulfate, Young Adult, Double-Blind Method, male, first in human study, medicine, controlled study, fenbendazole, viral gastroenteritis, business.industry, Cysticercosis, oxfendazole sulfone, renal clearance, intestine absorption, elimination rate constant, Fenbendazole, PR interval, business, drug dose escalation, plasma concentration-time curve

  2. 2
  3. 3